Log In
BCIQ
Print this Print this
 

Rifamycin SV MMX (CB-01-11)

  Manage Alerts
Collapse Summary General Information
Company Cosmo Pharmaceuticals N.V.
DescriptionBroad-spectrum, semisynthetic, oral non-absorbable antibiotic formulated with Multi-Matrix system (MMX) technology
Molecular Target
Mechanism of Action 
Therapeutic ModalityMacrocycle

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

07/08/2014

Undisclosed

0

0

Get a free BioCentury trial today